NCCN Guidelines® Insights: Cervical cancer, version 1.2024 Guidelines
| Authors: | Abu-Rustum, N. R.; Yashar, C. M.; Arend, R.; Barber, E.; Bradley, K.; Brooks, R.; Campos, S. M.; Chino, J.; Chon, H. S.; Crispens, M. A.; Damast, S.; Fisher, C. M.; Frederick, P.; Gaffney, D. K.; Gaillard, S.; Giuntoli, R.; Glaser, S.; Holmes, J.; Howitt, B. E.; Lea, J.; Mantia-Smaldone, G.; Mariani, A.; Mutch, D.; Nagel, C.; Nekhlyudov, L.; Podoll, M.; Rodabaugh, K.; Salani, R.; Schorge, J.; Siedel, J.; Sisodia, R.; Soliman, P.; Ueda, S.; Urban, R.; Wyse, E.; McMillian, N. R.; Aggarwal, S.; Espinosa, S. |
| Title: | NCCN Guidelines® Insights: Cervical cancer, version 1.2024 |
| Abstract: | The NCCN Guidelines for Cervical Cancer provide recommendations for all aspects of management for cervical cancer, including the diagnostic workup, staging, pathology, and treatment. The guidelines also include details on histopathologic classification of cervical cancer regarding diagnostic features, molecular profiles, and clinical outcomes. The treatment landscape of advanced cervical cancer is evolving constantly. These NCCN Guidelines Insights provide a summary of recent updates regarding the systemic therapy recommendations for recurrent or metastatic disease. |
| Keywords: | antineoplastic agent; antineoplastic combined chemotherapy protocols; pathology; uterine cervical neoplasms; uterine cervix tumor; humans; human; female |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 21 |
| Issue: | 12 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2023-12-01 |
| Start Page: | 1224 |
| End Page: | 1233 |
| Language: | English |
| DOI: | 10.6004/jnccn.2023.0062 |
| PUBMED: | 38081139 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Source: Scopus |
